Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.
Publication
, Journal Article
Pignone, M; Alberts, MJ; Colwell, JA; Cushman, M; Inzucchi, SE; Mukherjee, D; Rosenson, RS; Williams, CD; Wilson, PW; Kirkman, MS ...
Published in: Diabetes Care
June 2010
Duke Scholars
Published In
Diabetes Care
DOI
EISSN
1935-5548
Publication Date
June 2010
Volume
33
Issue
6
Start / End Page
1395 / 1402
Location
United States
Related Subject Headings
- United States
- Societies, Medical
- Platelet Aggregation Inhibitors
- Humans
- Endocrinology & Metabolism
- Diabetes Mellitus
- Diabetes Complications
- Cardiovascular Diseases
- Aspirin
- American Heart Association
Citation
APA
Chicago
ICMJE
MLA
NLM
Pignone, M., Alberts, M. J., Colwell, J. A., Cushman, M., Inzucchi, S. E., Mukherjee, D., … American College of Cardiology Foundation. (2010). Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care, 33(6), 1395–1402. https://doi.org/10.2337/dc10-0555
Pignone, Michael, Mark J. Alberts, John A. Colwell, Mary Cushman, Silvio E. Inzucchi, Debabrata Mukherjee, Robert S. Rosenson, et al. “Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.” Diabetes Care 33, no. 6 (June 2010): 1395–1402. https://doi.org/10.2337/dc10-0555.
Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care. 2010 Jun;33(6):1395–402.
Pignone, Michael, et al. “Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.” Diabetes Care, vol. 33, no. 6, June 2010, pp. 1395–402. Pubmed, doi:10.2337/dc10-0555.
Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS, American Diabetes Association, American Heart Association, American College of Cardiology Foundation. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care. 2010 Jun;33(6):1395–1402.
Published In
Diabetes Care
DOI
EISSN
1935-5548
Publication Date
June 2010
Volume
33
Issue
6
Start / End Page
1395 / 1402
Location
United States
Related Subject Headings
- United States
- Societies, Medical
- Platelet Aggregation Inhibitors
- Humans
- Endocrinology & Metabolism
- Diabetes Mellitus
- Diabetes Complications
- Cardiovascular Diseases
- Aspirin
- American Heart Association